Clinical Trial Update: Study Of Sunitinib With FOLFIRI In Colorectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports results for sunitinib in combination with the FOLFIRI regimen in patients with unresectable or metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Unresectable or Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-10-07